Sign inJoin waitlistJoin the waitlist

EV

Erik Vandendries

Hematology & Oncology

Credentials: ·

Research

Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
New England Journal of Medicine · 2016 · 1,107 citations
Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin
The Journal of Experimental Medicine · 2003 · 616 citations
Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long-term survival follow-up from the randomized, phase 3…
Cancer · 2019 · 292 citations

Hagop Kantarjian
20 papers
Anjali Advani
19 papers
Daniel DeAngelo
18 papers
Wendy Stock
14 papers
Elias Jabbour
13 papers
SO
Susan O'Brien
12 papers
Ryan Cassaday
11 papers
Michaela Liedtke
9 papers
BS
Barbara Sleight
7 papers
Akil Merchant
4 papers
Partow Kebriaei
4 papers
BF
Bruce Furie
3 papers